Tvardi Therapeutics, Inc. (TVRD) stock news · rev $7.1M
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
This TVRD news page leads with what Tvardi Therapeutics, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for TVRD yet. We will not pad this page with generic market recap.
Latest reported TVRD revenue for 2024-12-31 was $7.1M. Net income was -$70.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. TVRD currently screens at market cap $10.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TVRD stock page; for the tape open the quote page.
TVRD stock news FAQ
What are TVRD's latest revenue and net income?
Latest cached Tvardi Therapeutics, Inc. (TVRD) revenue for Dec 31, 2024 was $7.1M. Net income was -$70.9M. Statements: https://lician.com/financials/tvrd
How did TVRD revenue change from the prior cached period?
Cached Tvardi Therapeutics, Inc. (TVRD) revenue was down 66.0% from $21.0M (Dec 31, 2023) to $7.1M (Dec 31, 2024). Statements: https://lician.com/financials/tvrd
What is TVRD's market cap?
Tvardi Therapeutics, Inc. (TVRD) market cap is $10.0M on the latest cached fundamentals snapshot.
What kind of company is TVRD?
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
Where is TVRD stock news listed?
Cached stock news for Tvardi Therapeutics, Inc. (TVRD) is listed at https://lician.com/news/tvrd. Filings: https://lician.com/sec/tvrd
Not investment advice.